Found: 4
Select item for more details and to access through your institution.
Combination Therapy of RAS Inhibition and SGLT2 Inhibitors Decreases Levels of Endotrophin in Persons with Type 2 Diabetes.
- Published in:
- Biomedicines, 2023, v. 11, n. 11, p. 3084, doi. 10.3390/biomedicines11113084
- By:
- Publication type:
- Article
International Variability of Renal and Cardiovascular Outcomes and Mortality in Patients with Type 2 Diabetes Mellitus in Europe.
- Published in:
- Kidney & Blood Pressure Research, 2023, v. 48, n. 1, p. 165, doi. 10.1159/000528438
- By:
- Publication type:
- Article
Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1283, doi. 10.1007/s00125-024-06149-w
- By:
- Publication type:
- Article
Exploratory Study Analyzing the Urinary Peptidome of T2DM Patients Suggests Changes in ECM but Also Inflammatory and Metabolic Pathways Following GLP-1R Agonist Treatment.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13540, doi. 10.3390/ijms241713540
- By:
- Publication type:
- Article